Replies to post #522686 on NorthWest Biotherapeutics Inc (NWBO)

[hoffmann6383]

I see no basis to this statement in the linked article:

Either NWBO will have to drop their price way down or may have problems getting UK reimbursement.

On the other hand, this describes optune perfectly. In fact, Optune said as much in their recent UK presentation

[X Master]

Apparently you have not paid attention. Even at $200,000 DCVax is more cost effective than the helmet.

[Roman516]

Good to hear that the U.K. is a secondary market for pharmaceuticals based on MHRA approvals NWBO will be able to market beyond the U.K.